Bremelanotide Acetate (CAS 1607799?13?2) – Purity 99.98% | GMP Factory

描述

Bremelanotide acetate is a synthetic cyclic heptapeptide analog of ??melanocyte stimulating hormone (??MSH), functioning as a non-selective agonist of melanocortin receptors, especially MC1R and MC4R. MC4R activation is linked with CNS pathways regulating sexual desire and arousal. While its therapeutic mechanism remains not fully defined, it is FDA-approved for addressing hypoactive sexual desire disorder (HSDD) in premenopausal women.

This GMP-produced peptide (?99.98% purity) is optimized for preclinical studies on CNS function, sexual motivation, melanocortin signaling, and related neuroendocrine pathways.

For laboratory research use only. Not for human or clinical use.

Product Specifications

Mechanism of Action & Research Applications

Bremelanotide acetate targets melanocortin receptors, non-selectively activating MC1R and MC4R—key to melanocyte pigmentation and sexual behavior, respectively. Research applications include:

• Central nervous system studies on sexual desire and arousal

• Melanocortin signaling pathway investigations

• Behavioral pharmacology and neurotransmitter modulation

• Sexual dysfunction and neuroendocrine research

Side Effects (Research Context Only)

In experimental settings, activation of melanocortin receptors may result in:

• Transient blood pressure changes and heart rate fluctuation

• Nausea, injection site reactions, and pigmentation changes
  These outcomes have been mainly observed in clinical scenarios and are referenced here for research context only.

Disclaimer

This compound is strictly for laboratory research use only. It is not approved for human, clinical, or veterinary use. Use in compliance with institutional safety protocols only.